We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Sun Pharma’s ANDA for Generic Prostate Drug
FDA Approves Sun Pharma’s ANDA for Generic Prostate Drug
July 22, 2011
The FDA has approved Sun Pharmaceutical’s ANDA for a generic version of Sanofi’s prostate treatment Uroxatral XR, giving Sun 180 days of marketing exclusivity as the first filer.